Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility

This publication has 49 references indexed in Scilit:

• In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• Antimicrobial activity of cefepime tested against bush group I β-lactamase-producing strains resistant to ceftazidime a multilaboratory national and international clinical isolate study
  Diagnostic Microbiology and Infectious Disease, 1994
• Parenteral cephalosporin classification
  Expert Opinion on Investigational Drugs, 1994
• The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres
  Journal of Antimicrobial Chemotherapy, 1993
• -Lactamases of Gram-Negative Bacteria: New Challenges for New Drugs
  Clinical Infectious Diseases, 1992
• Antimicrobial activity of cefpirome an update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
  Diagnostic Microbiology and Infectious Disease, 1991
• Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection
  Journal of Antimicrobial Chemotherapy, 1991
• β-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant Gram-negative bacteria
  Journal of Antimicrobial Chemotherapy, 1991
• Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins
  European Journal of Clinical Microbiology & Infectious Diseases, 1990
• Activity of cefepime (BMY-28142) and cefpirome (HR 810) against Gram-negatire bacilli resistant to cefotaxime or ceftaxidime
  Journal of Antimicrobial Chemotherapy, 1989